Table 2.
Comparison of baseline sociodemographic, neurological, cognitive and emotional characteristics between patients included and not included at follow-up.
| Patients not included at follow-up (n = 22) |
Patients included at follow-up (n = 21) |
p value | |
|---|---|---|---|
| Age (years) | 62.5 ± 10.5 | 59.4 ± 11.6 | 0.40 |
| Sex (male/female) | 12/9 | 13/9 | 0.02 |
| Education level (in years) | 9.5 ± 3.0 | 10.3 ± 2.7 | 0.23 |
| ALSFRS | 35.8 ± 5.2 | 40.1 ± 4.6 | <0.01 |
| Norris scale | 34.1 ± 5.8 | 35.1 ± 6.5 | 0.26 |
| MRC | 101.9 ± 13.7 | 102.3 ± 17.1 | 0.65 |
| Spinal vs. Bulbar | 16/6 | 16/5 | 0.07 |
| BDI (/39) | 3.3 ± 2.6 | 6.6 ± 5.6 | 0.06 |
| STAI-Y 1 (/80) | 34.2 ± 10.7 | 35.7 ± 11.7 | 0.64 |
| STAI-Y 2 (/80) | 34.8 ± 9.6 | 37.7 ± 6.1 | 0.56 |
| TMT B-A time (s) | 62.0 ± 58.1 | 74.9 ± 63.6 | 0.90 |
| Animal VF Index | 3.6 ± 1.1 | 3.9 ± 1.0 | 0.13 |
| Letter VF Index | 6.6 ± 2.2 | 9.2 ± 8.3 | 0.23 |
| HSCT | 5.0 ± 2.6 | 5.8 ± 3.0 | 0.40 |
| LN sequencing | 9.0 ± 3.9 | 8.3 ± 3.8 | 0.67 |
| FET-eyes be | 6.0 ± 1.3 | 6.1 ± 1.é | 0.85 |
| FET-eyes ce | 5.0 ± 1.7 | 5.1 ± 1.7 | 0.85 |
| FET-face be | 7.0 ± 1.4 | 6.9 ± 1.9 | 0.87 |
| FET-face ce | 5.4 ± 1.6 | 5.7 ± 1.8 | 0.53 |
Values are mean ± SD. ALSFRS, ALS Functional Rating Scale; MRC, Medical Research Council Muscle Strength Scale; BDI, Beck Depression Inventory; STAI-Y, Spielberger State and Trait Anxiety Inventory; 1, State; 2, Trait; TMT, Trail Making Test; VF, Verbal Fluency; HSCT, Hayling Sentence Completion Test; LN sequencing, Letter-Number Sequencing task; FET, Face Eyes Test; be, basis emotions; ce, complex emotions. MDRS, Mattis Demencia Rating Scale; Significance set at p < 0.05.